Given ASM is a mandatory model that requires the reporting of a specific set of measures, compared to MIPS that allows for more flexibility in which measures a MIPS eligible clinician chooses to report, we believe that our scoring policies are fit-for-purpose so ASM participants will more easily understand how their performance will be determined under ASM
The clinical outcomes data is robust and the benefit-risk profile, in appropriate patient populations, is well established
Graphical Abstract Similar content being viewed by others Background Idiopathic intracranial hypertension (IIH) is a debilitating condition characterized by raised intracranial pressure causing chronic headaches and papilledema with the risk of permanent visual loss, which most commonly occurs in young obese women [1]
Similarly, HIV-1 ssRNA40 activates microglia, natural killer cells, dendritic cells, and macrophages [46, 172,173,174,175]
Abplanalp, W